PubRank

S O'Reilly

Author PubWeight™ 72.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989 6.86
2 Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensus. Rheumatology (Oxford) 2004 3.38
3 Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol 2001 3.27
4 Long term acid suppressing treatment in general practice. BMJ 1994 3.11
5 The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol 2013 2.41
6 The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000 2.17
7 Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space. Ann Rheum Dis 1998 2.01
8 Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 1994 1.84
9 Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 1994 1.66
10 The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial. Br J Cancer 1995 1.33
11 New approaches to treating oesophageal cancer. BMJ 1994 1.22
12 A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest 2000 1.20
13 Brain death--an opposing viewpoint. JAMA 1979 1.13
14 Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br J Pharmacol 1994 1.11
15 Herceptin (trastuzamab) in advanced breast cancer. Cancer Treat Rev 2000 1.10
16 A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. Hum Gene Ther 1998 1.07
17 Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat. Br J Pharmacol 1997 0.99
18 Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 2000 0.98
19 Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1995 0.94
20 Proteinases of the cornea and preocular tear film. Vet Ophthalmol 2007 0.93
21 Cross-linked actin networks (CLANs) in bovine trabecular meshwork cells. Exp Eye Res 2009 0.93
22 Effect of daily etidronate on the osteolysis of multiple myeloma. J Clin Oncol 1991 0.90
23 Metastatic uterine leiomyosarcoma presenting as a breast lump. Ir J Med Sci 2009 0.90
24 Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab. Curr Oncol 2012 0.89
25 Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line. Int J Radiat Biol 2000 0.89
26 Antitussive action of antihistamines is independent of sedative and ventilation activity in the guinea pig. Pharmacology 1998 0.87
27 Pharmacological studies of allergic cough in the guinea pig. Eur J Pharmacol 1995 0.87
28 Radiation myositis. Ann Oncol 1999 0.87
29 Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis. Ann Rheum Dis 2006 0.85
30 NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life. Br J Cancer 2008 0.85
31 Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues. Trans Am Neurol Assoc 1974 0.84
32 Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu. Clin Sci 1972 0.84
33 Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper. Arch Neurol 1971 0.83
34 Kinky hair disease. Study of copper metabolism with use of 67Cu. Arch Neurol 1975 0.83
35 Iron metabolism in Wilson's disease. Kinetic studies with iron. Neurology 1968 0.83
36 Ceruloplasmin and 5-hydroxyindole metabolism in pregnancy. Am J Obstet Gynecol 1967 0.82
37 Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assay. Br J Cancer 2003 0.82
38 Persistent expression of morphological abnormalities in the distant progeny of irradiated cells. Radiat Environ Biophys 1996 0.82
39 Amniotic membrane transplantation for corneal surface reconstruction after excision of corneolimbal squamous cell carcinomas in nine horses. Vet Ophthalmol 2006 0.82
40 Factors influencing intention to purchase beef in the Irish market. Meat Sci 2003 0.81
41 Reliability of the pediatric dysfunctional voiding symptom score in monitoring response to behavioral modification. Can J Urol 2001 0.81
42 Phase I and pharmacologic study of oral fluorouracil on a chronic daily schedule in combination with the dihydropyrimidine dehydrogenase inactivator eniluracil. J Clin Oncol 2000 0.80
43 Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors. Cancer Chemother Pharmacol 2001 0.80
44 Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995 0.80
45 Detection of the heterozygote of Wilson's disease. J Nucl Med 1969 0.80
46 Gastrointestinal absorption of copper: studies with 64Cu, 95Zr, a whole-body counter and the scintillation camera. J Nucl Med 1969 0.80
47 T/NK cell non-Hodgkin's lymphoma of the sinonasal tract. J Laryngol Otol 2001 0.80
48 4-Demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res 1997 0.80
49 Expression of lethal mutations is suppressed in neoplastically transformed cells and after treatment of normal cells with carcinogens. Radiat Res 1996 0.79
50 The economic and social cost of dementia in Ireland. Int J Geriatr Psychiatry 2000 0.79
51 Murine and human in vivo penclomedine metabolism. Clin Cancer Res 1996 0.79
52 Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Ann Oncol 1997 0.79
53 Dopamine and basal ganglia disorders. Neurology 1965 0.78
54 Pigment binding of copper in human bile. Clin Chim Acta 1977 0.78
55 Factors influencing consumption of pork and poultry in the Irish market. Appetite 2004 0.78
56 Use and benefits of a Web site for pancreatic cancer. JAMA 1998 0.77
57 Studies of the carcinoid syndrome: its relationship to serotonin, bradykinin, and histamine. Surgery 1967 0.77
58 High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors. Br J Cancer 1998 0.77
59 Efficacy of camptothecin in progressive multifocal leucoencephalopathy. Lancet 1997 0.76
60 Radiation-induced carcinogenesis: studies using human epithelial cell lines. Radiat Oncol Investig 1997 0.76
61 High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study. Ann Oncol 1998 0.75
62 Topotecan: what dose, what schedule, what route? Clin Cancer Res 1999 0.75
63 Evan's blue dye blocks capsaicin-induced cough and bronchospasm in the guinea pig. Eur J Pharmacol 1995 0.75
64 Empathy and the wounded healer: a mixed-method study of patients and doctors views on empathy. Ir Med J 2015 0.75
65 Anaplastic carcinoma of the thyroid following radio-iodine therapy. Ir J Med Sci 1993 0.75
66 The relationship between 5-hydroxyindoles and catecholamines. Neurology 1965 0.75
67 Myasthenia gravis associated with cyclosporin treatment. Nephrol Dial Transplant 1992 0.75
68 Diffuse glioma of the spinal cord with hypoglycorrhachia. Neurology 1966 0.75
69 Breast cancer metastatic to the choroid. J Clin Oncol 1998 0.75
70 Taxane-resistant lymphoepithelial-like carcinoma: excellent response to VIP chemotherapy. Ir J Med Sci 2006 0.75
71 Neurologic disorders and liver disease. Postgrad Med 1971 0.75
72 Decreased vision as the initial presenting symptom of disseminated prostatic disease. Eye (Lond) 2005 0.75
73 TEXAS (Taxotere EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC. Cancer Chemother Pharmacol 2006 0.75
74 Unilateral nail changes secondary to adriamycin: the protective effect of brachial plexopathy. Ann Oncol 2005 0.75
75 An evaluation of the azocoll colorimetric assay for quantitating proteolytic enzymes. Acta Cient Venez 1981 0.75
76 Problems in Wilson's disease. Neurology 1967 0.75
77 Dopa in Parkinson's disease. Lancet 1969 0.75
78 Heredofamilial tremor. A case study. Med Ann Dist Columbia 1971 0.75
79 Vascular characterization of brain lesions by rapid sequential cranial scintiphotography. J Nucl Med 1968 0.75
80 Life-threatening myelosuppression in patients with occult renal impairment receiving topotecan. Gynecol Oncol 1997 0.75
81 Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper. Arch Neurol 1971 0.75
82 Development and multisite evaluation of an automated assay for B12 on the Abbott AxSYM analyzer. Clin Chem 1999 0.75
83 Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper. Arch Neurol 1971 0.75
84 A phase I-II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer. Ann Oncol 1998 0.75
85 Irish consultants' attitudes towards the climate of increasing medical litigation in Ireland. Ir Med J 2005 0.75